Recent
price
P/E
ratio
div
yld
5.90%
ROIC.AI
What the Rich and Powerful Will Be Doing in Davos
Is Pfizer Stock A Sell After Two Years In Free Fall? Or Will Seagen Bolster Sales?
Pfizer, Genmab Get Speedy FDA Review of Tivdak Full Approval
Is Pfizer Stock A Sell After Two Years In Free Fall? Or Will Seagen Bolster Sales?
Moderna Stock Is Top Performer in S&P 500 After Miserable 2023. Why This Year Could Be Better.
Here are the 20 worst-performing stocks among the S&P 500 in 2023
Here are the 20 worst-performing stocks among the S&P 500 in 2023
Rate-Cut Hopes, AI, No Recession This Year. Why Stocks Will Find 2024 Tougher.
The Biggest Losers in S&P 500 This Year: Dollar General, Moderna, and More
S&P 500 Is Nearing a Record High. This Could Derail It in 2024.
Moderna and Pfizer Stock Tumbled in 2023. Wall Street Sees a Rebound.
Fusion Pharma climbs as radiopharmaceutical company flagged as potential merger target
Can Obesity Firms Continue Their Outperformance in 2024?
Investors Lose $426 Billion On These 8 Giant Losers This Year
13 stocks that are down for 2023 but may bounce back in 2024 or beyond
13 stocks that are down for 2023 but may bounce back in 2024 or beyond
What to Know About the New Fast-Spreading Covid-19 Strain
Is Pfizer Stock A Sell After Its 2024 Outlook Disappoints And Weighs On Shares?
Illumina to Sell Grail. It’s Giving Up on Its Biotech Antitrust Battle.
The Score: Macy’s, Hasbro, Pfizer and More Stocks That Defined the Week
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.